Navigation Links
The Michael J. Fox Foundation Launches New Funding Opportunities for Parkinson's Research
Date:2/20/2013

NEW YORK, Feb. 20, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation (MJFF) is today announcing the launch of four new funding programs focused on driving forward research toward transformative treatments and a cure for Parkinson's disease (PD). MJFF places a strong emphasis on translational and clinical research, but also supports high-risk/high-reward discovery work to help keep new ideas flowing into the drug development pipeline.

The new funding opportunities are open to both academic and industry researchers. Projects should promote PD drug development around the most promising therapeutic pathways and targets, including leading genetic targets alpha-synuclein and LRRK2.

Researchers can also apply for access to MJFF's growing inventory of tissue samples from pre-clinical models and clinical populations for projects seeking to address promising Parkinson's ideas. 

In addition to the four launching programs, four other rolling programs are currently open and accepting applications.  Check out the complete list and apply for funding at https://www.michaeljfox.org/research/apply-for-grant.html.

Brief descriptions of the launching programs follow. 

MJFF Biosample and Tissue Resource RFA - Fall 2013
MJFF has supported several pre-clinical and clinical efforts to generate valuable biospecimen tissue resources for the research community. This is an opportunity for researchers to apply to use these samples.

Informational Conference Call: March 6, 2013 at 12pm US EST
Pre-Proposals Due: April 3, 2013
To participate in the call and receive call-in details, please RSVP via email to conferencecalls@michaeljfox.org.

LRRK2 Pharmacodynamic Assays 2013
MJFF seeks to support projects to identify, generate and validate measures and assays of the function of the protein leucine-rich repeat kinase 2 (LRRK2) that accelerate development and testing of LRRK2-targeted therapies for PD. Successful applicants will be granted membership in the MJFF LRRK2 Consortium, where they can share information, data and resources with awardees of this and other LRRK2-related efforts.

Informational Conference Call: March 5, 2013 at 12pm US EST
Pre-Proposals Due: April 3, 2013
To participate in the call and receive call-in details, please RSVP via email to conferencecalls@michaeljfox.org.

Therapeutic Pipeline Program - Fall 2013
The goal of the Therapeutic Pipeline Program is to support therapeutic development around targets within pathways that have been implicated in altering the course of PD. Proposals may seek support of key steps along the entire therapeutic pipeline, including therapeutic screening, identification and optimization, pre-clinical in vivo testing and clinical testing.

Applicants are asked to develop a clear plan, including major 'go/no go' decision milestones, for moving a therapeutic strategy toward clinical utility in people with PD.  Investigators new to PD research are encouraged to collaborate with experienced PD scientists and/or companies to ensure the greatest chance for success.

Informational Conference Call: March 7, 2013 at 12pm US EST
Pre-Proposals Due: April 3, 2013
To participate in the call and receive call-in details, please RSVP via email to conferencecalls@michaeljfox.org.

Synuclein Therapeutic Acceleration Program (SynTAP 2013)
MJFF seeks to aggressively move therapeutic compounds and biologics targeting alpha-synuclein into clinical testing by funding mid to late-stage pre-clinical development work. Studies should be designed to obtain data required for Investigational New Drug application submission, and for future clinical testing of the therapeutic. 

Informational Conference Call: March 13, 2013 at 12pm US EDT
Pre-Proposals Due: April 3, 2013
To participate in the call and receive call-in details, please RSVP via email to conferencecalls@michaeljfox.org.

About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers.  In addition to funding more than $300 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.

For more information, visit us at:
Web site: michaeljfox.org 
Facebook: facebook.com/michaeljfoxfoundation 
LinkedIn: bit.ly/mjffPDOR 
Twitter: @MichaelJFoxOrg


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
2. Raleigh CoolSculpting Complete Provides Twice the Fat Elimination in Just One Hour Now Available at Michael Law MD Aesthetic Plastic Surgery
3. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
4. The Michael J. Fox Foundation Announces Fourth Quarter Participants in Partnering Program Between Awardees and Industry
5. Michael Epstein joins MedSpan Research as Director, Research Services
6. Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
7. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
8. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
9. Response to U.S. Supreme Courts Healthcare Decision by Michael Zamagias, Chairman, TeleTracking Technologies
10. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
11. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocythemia Market and ... to their offering.       ... ,The latest research Europe Thrombocythemia Market ... provides comprehensive insights into Thrombocythemia pipeline ...
(Date:5/4/2016)... May 4, 2016  Compass Diversified Holdings (NYSE: ... an owner of leading middle market businesses, announced today ... March 31, 2016. First Quarter 2016 Highlights ... Reinvestment ("CAD" or "Cash Flow") of $13.6 million for ... loss of $15.0 million for the first quarter of ...
(Date:5/4/2016)... May 4, 2016 According to market ... and Demand Forecast to 2022 - Industry Insights by Slice ... Center and Others)" by P&S Market Research, the global ... 2015, and it is expected to grow at a CAGR ... slice type segment is expected to witness the faster growth, ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... ... From the Speaker Podium to the Exhibit Floor at Booth#514, Worldwide Leading Contact Center ... at SpeechTek 2016 Event, taking place May 23-25 at the Omni Shoreham in Washington ... “5 Customer Engagement Strategies to improve Customer Satisfaction in your Contact Center” on May ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning ... and operated for over 35 years. Maintaining core values of exceptional customer service, quality ... and made them a leading name in San Diego plumbing, and other services including ...
(Date:5/6/2016)... ... May 06, 2016 , ... This Mother’s Day kicks off the ... 17th annual National Women’s Health Week takes place May 8-May 14. , ... combining forces to empower women to make their health a top priority. Women everywhere ...
(Date:5/5/2016)... Viejo, CA (PRWEB) , ... May 05, 2016 , ... ... in Final Cut Pro X. Drag and drop a TransWipe preset between two video ... Choose from smooth corner wipes to colored panels with customizable color and orientation options. ...
(Date:5/5/2016)... Lubbock, Texas (PRWEB) , ... May 05, 2016 , ... ... of the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is ... ensure that it meets its goals and delivers value to the wool industry., The ...
Breaking Medicine News(10 mins):